Simplex Trading, LLC Biocept Inc Transaction History

Simplex Trading, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 27, 2023	SELL	$0.24 - $0.62 $790 - $2,041	-3,293 Reduced 87.39%	475 $0
Q4 2022 Feb 02, 2023	SELL	$0.47 - $0.89 $1,137 - $2,153	-2,420 Reduced 39.11%	3,768 $1,000
Q3 2022 Nov 04, 2022	BUY	$0.75 - $1.2 $326 - $522	435 Added 7.56%	6,188 $5,000
Q2 2022 Aug 03, 2022	BUY	$0.88 - $2.27 $5,062 - $13,059	5,753 New	5,753 $5,000
Q1 2022 May 02, 2022	SELL	$1.83 - $3.97 $48,026 - $104,188	-26,244 Closed	0 $0
Q4 2021 Feb 23, 2022	BUY	$3.43 - $4.22 $90,016 - $110,749	26,244 New	26,244 $95,000
Q2 2021 Aug 12, 2021	SELL	$4.03 - $5.07 $121,758 - $153,179	-30,213 Closed	0 $0
Q1 2021 Apr 26, 2021	BUY	$4.74 - $7.94 $143,209 - $239,891	30,213 New	30,213 $153,000

Ticker BIOC
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 16,922,900
Market Cap $1.18M
Description
Biocept, Inc., a molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell and circulating cell-free tumor DNA and RNA assays utilizing a standard blood sample. Its cancer assays provide information to healthcare providers to identify oncogenic alterations that qualify a subset of cancer patients for ...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.